IntroductionThe etiology and evolution of respiratory viruses remain threats to public health that necessitate continued scientific investigation. The recent COVID-19 pandemic has placed coronaviruses under unprecedented global scrutiny, with the XEC variant being the latest addition to the Omicron lineage. Concurrently, the discovery of HKU5-CoV-2 in bats has been worrying due to its capacity to infect human cells using the ACE2 receptor, much like SARS-CoV-2. Parallel to this, Human Metapneumovirus (hMPV), a previously long-documented respiratory infection pathogen, continues to circulate globally, causing severe respiratory illness, particularly in vulnerable subjects. This comparative study aims to explore the molecular forms, modes of transmission, and clinical importance of the viruses, illuminating the unique features as well as the shared pathogenic pathways(Ahmed, 2024d).The XEC strain, first detected in Germany in mid-2024, later gained prominence due to its increased transmissibility and immune system evasion ability. XEC was reported to have multiple spike protein mutations that make it more effective to bind to the ACE2 receptor while avoiding neutralizing antibodies induced by prior infection or immunization. Its heightened fitness has also caused widespread spread in several regions, posing its potential to prolong the pandemic. Despite its clinical presentation generally resulting in milder symptoms than prior SARS-CoV-2 variants, the rapid spread of XEC underscores the virus’s ongoing evolution and adaptation and poses an ongoing challenge to public health interventions and vaccine effectiveness(Ahmed, 2024g).HKU5-CoV-2, a newly identified bat coronavirus, was particularly significant because it could infect human cells through the ACE2 receptor, as in SARS-CoV-2. HKU5-CoV-2’s genome closely resembles MERS-CoV and other zoonotic coronaviruses, discovered during bat surveillance. Although lab experiments indicate decreased human infectivity relative to COVID-19, cross-species transmission and genetic recombination capacity of HKU5-CoV-2 are problematic for concerns of future spillover. This finding highlights the need for surveillance of animal reservoirs and elucidation of zoonotic transmission routes to avoid possible outbreaks.On the other hand, hMPV, a Pneumoviridae family member, has a different virological profile. Unlike coronaviruses, hMPV does not have the mechanism of entry via the spike protein but rather through the fusion (F) protein to infect host cells. Clinically, hMPV has been identified as a cause of upper and lower respiratory tract infections with severe manifestations most frequently occurring in infants, elderly, and immunocompromised individuals. Recent epidemiological data have indicated rising rates of hospitalization of hMPV infection, particularly with seasonal epidemics, necessitating concern regarding its impact on healthcare resources. Notably, hMPV infection leads to complications of pneumonia and bronchiolitis, which make it a significant cause of respiratory illnesses worldwide(Ahmed, 2024r).By comparing molecular structures, patterns of transmission, and clinical impact of XEC, HKU5-CoV-2, and hMPV, this study aims to develop greater insights into viral pathogenesis and mechanisms of immune evasion. Comparative examination of the viruses alongside each other not only heightens awareness of their individual actions but also unearths broader relevance for pandemic preparedness and targeted therapy design. Understanding the evolutionary history of these viruses, host adaptation, and clinical presentation is crucial to guiding future efforts and strengthening global health responses to emerging respiratory pathogens(Ahmed, 2024q).